How do I set a price alert for AVCN.TO?

To set a AVCN.TO price alert on Stock Alarm Pro, navigate to the AVCN.TO quote page, select "Set Alert," choose your trigger type (price target, % move, RSI level, MACD, or volume breakout), and set your delivery channel. Stock Alarm Pro supports instant push notifications, SMS, and automated phone call alerts.

Can I get phone call alerts for AVCN.TO?

Yes. Stock Alarm Pro provides real-time automated phone call alerts for AVCN.TO. Phone call alerts ensure you are immediately awakened or interrupted during critical volatility events, overnight earnings moves, or strict stop-loss levels when silent push notifications might be overlooked.

What types of alerts can I set for AVCN.TO?

Stock Alarm Pro supports over 125 trigger types for AVCN.TO: price target alerts (above/below target), intraday percentage moves, RSI overbought/oversold levels, 50-day and 200-day moving average crossovers (golden cross / death cross), relative volume (RVOL) spikes, confirmed earnings date releases, and SEC Form-4 insider transaction filings.

How quickly will I be notified about AVCN.TO price changes?

AVCN.TO alerts are evaluated continuously in real-time against live market telemetry. Notifications are dispatched within sub-second latency via push notifications, SMS, or phone calls as soon as your trigger condition is met across regular, pre-market, and after-hours trading sessions.

Is Stock Alarm Pro free to use for AVCN.TO alerts?

Yes, Stock Alarm Pro offers a free tier that includes 3 active price alerts for AVCN.TO and other stocks. Full Pro membership is $20/month or $168/year with a 7-day free trial, unlocking unlimited alerts, phone call delivery, SMS, all 125+ technical indicators, institutional screeners, and real-time market telemetry across web, iOS, and Android.

AVCN.TO Company Intelligence - Business Model, Drivers & Risks

AVCN.TO(AVCN.TO)

$0.10—Stale · unknown old

WatchlistAsk SA Chart

AVCN.TO(AVCN.TO)

TSX • Last print unknown ago

$0.10—Stale · unknown old

WatchlistAsk SA Chart Studio

AVCN.TO(AVCN.TO)

AVCN.TO

Avicanna Inc. is a Canadian biopharmaceutical company focused on the development and commercialization of cannabis-based products for medical use. The company operates in Canada and has a growing presence in international markets, leveraging its proprietary formulations and research-driven approach to differentiate itself in the competitive cannabis landscape.

HealthcareDrug Manufacturers - Specialty & Genericlow - The company has high fixed costs associated with R&D and regulatory compliance, which limits its ability to scale efficiently without significant revenue growth.

Business Overview

01Cannabis-based pharmaceuticals (estimated 70% of total revenue)

02Cannabis oils and topicals (estimated 20% of total revenue)

03Research and development services (estimated 10% of total revenue)

Avicanna generates revenue primarily through the sale of cannabis-derived pharmaceuticals and wellness products, which are sold through both direct-to-consumer channels and partnerships with healthcare providers. The company benefits from a strong R&D pipeline and regulatory compliance in Canada, allowing for premium pricing on its products.

What Moves the Stock

Regulatory changes in Canada and international markets affecting cannabis legality

Partnership announcements with healthcare providers or distributors

Clinical trial results impacting product efficacy and market potential

Market expansion into new geographies, particularly in Europe and Latin America

Watch on Earnings

Revenue growth rateGross margin percentageClinical trial progress updates

Risk Factors

Regulatory changes that could impact the legality of cannabis products in key markets

Technological disruption in cannabis cultivation and extraction methods

Increasing competition from both established pharmaceutical companies and new entrants in the cannabis space

Potential market saturation in the Canadian cannabis market

Negative cash flow impacting operational sustainability

High reliance on external funding for R&D and expansion

StructuralCompetitiveBalance Sheet

Macro Sensitivity

Economic Cycle

moderate - The demand for medical cannabis products is somewhat insulated from economic cycles, but overall consumer spending can impact sales.

Interest Rates

Low - As a company with no debt, Avicanna is not significantly affected by rising interest rates, but higher rates could dampen consumer spending on discretionary health products.

Credit

minimal

Live Conditions

Dow Jones FuturesS&P 500 FuturesRussell 2000 Futures